Table 4 Outcomes in the BRSS and non-BRSS groups
| Â | BRSS group | non-BRSS group | p-value |
|---|---|---|---|
|  | n = 24 | n = 70 |  |
Major bleeding events, n (%) | 1 (4.2) | 4 (5.7) | 1.000 |
Minor bleeding events, n (%) | 1 (4.2) | 19 (27.1) | 0.020 |
VTE, n (%) | 1 (4.2) | 6 (8.6) | 0.674 |
Inappropriate use, n (%) | 2 (8.3) | 12 (17.1) | 0.507 |
Contraindication, n (%) | 0 (0) | 0 (0) | NA |
Contraindicated medicines, n (%) | 0 (0) | 0 (0) | NA |
Off-label use, n (%) | 2 (8.3) | 9 (12.9) | 0.723 |
Under dosing, n (%) | 0 (0) | 2 (2.9) | 1.000 |
Over dosing, n (%) | 0 (0) | 1 (1.4) | 1.000 |
Length of stay in emergency center, median (IQR) | 17.5 (13.5–39.0) | 19.50 (14.3–32.8) | 0.696 |
Hospital length of stay, median (IQR) | 43.5 (28.5–72.8) | 48.5 (36.0–59.8) | 0.955 |
The duration of prophylactic anticoagulation, median (IQR) | 11.5 (7.0–14.0) | 14.0 (11.3–14.0) | 0.004 |